Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate
(20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Andrzej Nycz
- Chris Masuo
- Luke Meyer
- William Carter
- Alexandre Sorokine
- Alex Walters
- Bruce Hannan
- Bruce Moyer
- Clinton Stipek
- Daniel Adams
- Debjani Pal
- Jeffrey Einkauf
- Jennifer M Pyles
- Jessica Moehl
- Joshua Vaughan
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Loren L Funk
- Luke Sadergaski
- Mike Zach
- Padhraic L Mulligan
- Peter Wang
- Philipe Ambrozio Dias
- Polad Shikhaliev
- Sandra Davern
- Taylor Hauser
- Theodore Visscher
- Viswadeep Lebakula
- Vladislav N Sedov
- Yacouba Diawara

Understanding building height is imperative to the overall study of energy efficiency, population distribution, urban morphologies, emergency response, among others. Currently, existing approaches for modelling building height at scale are hindered by two pervasive issues.

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

ORNL has developed a large area thermal neutron detector based on 6LiF/ZnS(Ag) scintillator coupled with wavelength shifting fibers. The detector uses resistive charge divider-based position encoding.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence